2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib
about
Heart Failure: a Major Cardiovascular Complication of Diabetes Mellitus'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulationVeno-arterial extracorporeal membrane oxygenation: an overview of different cannulation techniquesFrom ARB to ARNI in Cardiovascular ControlLong-term use of secondary prevention medications for heart failure in Western Australia: a protocol for a population-based cohort studyRole of circulating factors in cardiac aging.Addressing the Heterogeneity of Heart Failure in Future Randomized Trials.Prophylactic implantable cardioverter defibrillator in heart failure: the growing evidence for all or Primum non nocere for some?Ambulatory pulmonary artery pressure monitoring in advanced heart failure patients.Management standards for stable coronary artery disease in India.2016 ESC and ACC/AHA/HFSA heart failure guideline update - what is new and why is it important?Stress echo 2020: the international stress echo study in ischemic and non-ischemic heart disease.Advanced heart failure: an appraisal of the potential of levosimendan in this end-stage scenario and some related ethical considerations.Too weak to withstand the strain: another piece in the CRT puzzle.Who are patients classified within the new terminology of heart failure from the 2016 ESC guidelines?Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) studyThe cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners.Plasma Long Noncoding RNA Urothelial Carcinoma Associated 1 Predicts Poor Prognosis in Chronic Heart Failure Patients.Influenza infection and heart failure-vaccination may change heart failure prognosis?Degree of dyspnoea at admission and discharge in patients with heart failure and respiratory diseases.Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: The PrEP Registry.Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.Interatrial shunt devices for heart failure with normal ejection fraction: a technology update.Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.Cardiac damage in athlete's heart: When the "supernormal" heart fails!Effect of a 6-month pedometer-based walking intervention on functional capacity in patients with chronic heart failure with reduced (HFrEF) and with preserved (HFpEF) ejection fraction: study protocol for two multicenter randomized controlled trialsImmunohistochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients.Heart rhythm characterization through induced physiological variables.Muscle wasting and cachexia in heart failure: mechanisms and therapies.NT-proBNP Predicts Cardiovascular Death in the General Population Independent of Left Ventricular Mass and Function: Insights from a Large Population-Based Study with Long-Term Follow-Up.Serum insulin-like growth factor-1 and its binding protein-7: potential novel biomarkers for heart failure with preserved ejection fraction.An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial.The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.Findings of transoesophageal echocardiogram in appropriately anticoagulated patients with persistent atrial fibrillation prior to planned cardioversion.Automated Classification of Severity in Cardiac Dyssynchrony Merging Clinical Data and Mechanical DescriptorsEffects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysis.Transcultural adaptation and validation of the patient empowerment in long-term conditions questionnaire.Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysisAssociation of Central Sleep Apnea with Impaired Heart Structure and Cardiovascular Hemodynamics in Patients with Chronic Heart Failure
P2860
Q28066310-5E1B7390-F1F2-4D2E-86E9-F1C8E9D16E44Q28066921-08CEABF6-560B-4A04-B05E-A7AA54C2116DQ28071985-B981AF38-CF52-4BAA-BA27-FAF69BA3E4D8Q28073372-FABAF42D-FDA7-4D3A-89AC-2A203C4555F4Q28591667-A07534F9-0DC1-4EA3-B4EF-2691C523A61AQ30234641-4923F694-6062-4E6A-92EF-5E48DFFB6827Q30234708-E2F6B62E-83CA-49DA-932F-0DF61B4383E8Q30235600-094E97F4-58DD-4089-8E78-3C7A5378ED3FQ30238535-7D478056-7057-46C4-B91A-DC46BE39E48BQ30239853-55FA1215-1A0F-4328-AD00-603589147ED6Q30245381-5055278C-F2BD-431C-A3A3-9354A248A98DQ30365196-24602B67-454D-4EFA-9CAE-E6B49E4FC11FQ30394479-CB00544D-4DE1-4D05-8C5B-74B16BD52398Q33364548-8659AA47-8D03-4FC4-BB77-42D6CA738978Q33577412-888FD097-9396-4DB0-9D08-E69DAAA5F01DQ33589713-0FCFCBC2-76FC-4362-BACD-BC63113E8A75Q33697820-EB7DAE6A-1A70-4A6B-A077-CBC6A90382E6Q33700880-44802D84-5C5F-470A-A43E-54E9EA94FE8DQ33703155-5301F344-8022-49AF-9DE2-D84278A90228Q33708693-A0C5FF58-03E1-4B2F-8AC6-5A7C360E128CQ33717352-A51E265C-1AC7-4F12-B25D-930F6371840CQ33720452-ED764CC8-17E4-45CC-88BD-B2749B116966Q33727302-D5B42929-8ED6-4D27-9818-83AAE0AD7C37Q33812836-6C058707-D77F-456C-9559-478AF128F732Q33845755-D8C88A24-BDAA-4DFF-97C4-B80D93C4F830Q33854111-5B41211F-DADB-485F-B7C3-96C35CE4C536Q33868235-05D7098C-18E0-4FC3-B69E-00BA4789580EQ33883873-035DE856-9939-4CB7-9DBB-86C709AB8C92Q33894904-761FE75D-2D96-48D0-B36A-BC0EE6DBBEADQ34681621-5ECE30BC-3CE4-4A5D-A079-51E1B313DD4FQ36155133-FAD13BCF-C249-4B55-9255-A86554CA47A1Q36171125-B4FC34C2-A5B6-4D87-8456-A6520C6677C0Q36176870-37586475-1A5C-4F97-B5A6-14333F85F03BQ36225206-6E4C0F4E-5B20-4DB5-AB43-DA1696056440Q36287783-D4F109D9-3636-4F0A-A74F-2172C83C1B38Q36324748-625B5672-E1F9-4EE6-9BF3-F0DBDE1DFF4EQ36354815-2332A696-CF8C-4406-8F18-382E87DA2321Q36363650-2523C232-A71D-44D7-920F-179242011124Q36410691-A390C02B-EB56-4951-96C2-55963675E7D0Q37229659-64E1B326-D076-49A3-843A-0525E9420574
P2860
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
2016 ESC Guidelines for the di ...... loped with the special contrib
@ast
2016 ESC Guidelines for the di ...... loped with the special contrib
@en
2016 ESC Guidelines for the di ...... European Society of Cardiology
@nl
type
label
2016 ESC Guidelines for the di ...... loped with the special contrib
@ast
2016 ESC Guidelines for the di ...... loped with the special contrib
@en
2016 ESC Guidelines for the di ...... European Society of Cardiology
@nl
prefLabel
2016 ESC Guidelines for the di ...... loped with the special contrib
@ast
2016 ESC Guidelines for the di ...... loped with the special contrib
@en
2016 ESC Guidelines for the di ...... European Society of Cardiology
@nl
P2093
P50
P356
P1476
2016 ESC Guidelines for the di ...... loped with the special contrib
@en
P2093
Adriaan A Voors
Andrew J S Coats
Authors/Task Force Members
Document Reviewers
Frans H Rutten
Giuseppe M C Rosano
Jillian P Riley
John G F Cleland
John T Parissis
José Ramón González-Juanatey
P304
P356
10.1002/EJHF.592
P50
P577
2016-05-20T00:00:00Z